Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Parkinson’s disease

Multimodal exercise improves Parkinson’s disease symptoms

People with mild to moderate Parkinson’s disease who took part in a weekly one-hour multimodal circuit class over periods of one, two and three years have shown an increase in their cognitive performance.

Person with Parkinson's disease


Research has shown that both physical and mental exercise can improve function in people living with Parkinson’s disease

Exercise plans involving both physical and mental challenges, may improve outcomes in people with Parkinson’s disease (PD), research presented at the Future Physiology conference (17–18 November 2019) has shown[1].

The small study involved 25 participants with mild to moderate PD who took part in a weekly one-hour community-based multimodal circuit class over periods of one, two and three years. Patients were assessed at baseline and every four months thereafter.

There was an increase in the mini-mental Parkinson’s test from baseline to eight months onwards, demonstrating improved cognitive performance. Standardised physical tests, such as bilateral grip strength and the six-minute walking test did not significantly decrease over any of the time periods studied and there was improvement in the number of one minute sit-to-stands after the first four months, from 21 to 23.

Previous research has shown that both cognitive and physical exercises can improve function in people with PD. The researchers said that these findings indicated that combining the two types of exercise could slow down progression of the disease. They noted that in the absence of treatment, PD symptoms would be expected to worsen.

“That functional and cognitive performance were slightly increased or maintained is a positive outcome given the progressive nature of Parkinson’s,” the researchers concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207634

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.